SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia's reported acquisition of Hugging Face for $12.9B is fueling discussion, with retail investors viewing it as a strategic move to strengthen its AI ecosystem beyond chips, though some are weighing the potential competitive pressure on cloud partners like Microsoft.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, Europe, the Middle East and Africa (EMEA), and Asia-Pacific (APAC). Its brands include Abercrombie and Hollister. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

ANF is ripping on a Q2 blowout that crushed EPS estimates and fueled a sharp FY26 guidance raise, igniting intense bullish momentum and a massive short squeeze as traders pile in on the back of the strong beat and Jefferies' fresh $175 target. Community sentiment is split between those calling the tariff-refund-boosted quarter a one-time sugar high and betting on a fade, and momentum traders who see this as an explosive breakout with more upside to come.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as retail traders react to the reported collapse of a potential Trian take-private bid, which triggered a sharp selloff and fueled intense debate over whether the drop is a manipulation-driven gift or a sign of fading upside. The community is split between those framing it as a fresh squeeze setup due to high short interest and others warning the fundamental turnaround story remains weak.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

KURA is surging to fresh 52-week highs as the CEO's aggressive open-market share purchases fuel retail confidence, with traders highlighting the insider accumulation as a bullish signal and speculating on potential acquisition interest from its partner. The broader biotech chatter centers on the stock's strong momentum and the belief that high short interest could amplify the move.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is trending as the recent announcement of a joint venture with LS Electric, combined with a U.S. executive order restricting foreign grid equipment, is seen as a major win for domestic power infrastructure. Retail sentiment is focused on the company's pivotal role in the AI-driven electrification boom, viewing the moves as strengthening its already massive backlog and long-term demand outlook.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

CMPS is trending on a federal SAMHSA report signaling that COMP360 is likely to be the first FDA-approved psychedelic medicine, fueling community speculation about an imminent buyout and sector-wide momentum following recent big pharma deals.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Retail sentiment on Stocktwits flipped sharply bullish after Salesforce crushed Q2 estimates with EPS of $5.90, raised full-year guidance ~20%, and unveiled its Claudeforce partnership with Anthropicsparking chatter about the 'SaaSpocalypse' narrative being dead and fueling expectations for a continued melt-up. Traders are hyped on the AI-driven momentum and a potential reversal toward prior highs, with many eyeing $250-$300.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

The stock is trending as retail traders weigh a fresh U.S. Army Switchblade order and a Greek manufacturing JV against a brutal pullback from highs, with the community split between calling the dip a buying opportunity and warning of further downside into earnings. Defense drone chatter mixes with frustration over persistent weakness in the sector despite escalating geopolitical catalysts.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Traders are hammering GOOG, calling it a 'POS' and predicting a slide toward $300 despite NVDAs blowout earnings, which they view as a negative catalyst for hyperscaler margins. The dip is largely tied to fears over AI capex and debt, though some see Buffetts massive stake as a long-term floor.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is under pressure as retail sentiment turns extremely bearish, with traders frustrated by persistent downside and sideways action despite the broader AI narrative staying strong. The immediate focus is on reports that China's Moonshot AI is in early revenue-sharing talks with Google Cloud over hosting its Kimi K3 model, a deal that could open new AI monetization avenues but also carries geopolitical risk. Community chatter highlights GOOGL's perceived underperformance versus Nvidia's explosive growth and questions the payoff from massive AI infrastructure spending, though some see the current valuation as a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

KNSA lifted 2026 ARCALYST sales guidance as Q2 revenue surged, while advancing KPL-387 into Phase 3 to support its next growth driver.

MDGL Stock Down Despite Q2 Beat, MASH Drug Drives Top-Line Y/Y Growth

Madrigal beats Q2 estimates as Rezdiffra sales lift revenues 71% year over year, but shares fall as investors weigh slower commercial growth.

Teva Q2 Earnings Lag Estimates, 2026 Revenue View Raised, Stock Rises

TEVA misses Q2 earnings estimates as Emalex acquisition costs weigh on profits, while innovative drugs drive a revenue beat and an increased 2026 sales outlook.

Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?

Kiniksa Pharmaceuticals International, plc (KNSA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down

ALKS posts break-even Q2 earnings and tops revenue estimates as product sales surge, with Lumryz adding momentum. The company maintains its 2026 revenue view.

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 Earnings Match Estimates

Kiniksa Pharmaceuticals International, plc (KNSA) delivered earnings and revenue surprises of 0.00% and +7.09%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

EU Clears AZN's Etcamah Combo for First-Line ER-Positive Breast Cancer

AstraZeneca secures EU approval for Etcamah in combination with a CDK4/6 inhibitor for first-line treatment of advanced ER-positive breast cancer patients.

Zacks.com featured highlights include American Outdoor Brands, Cimpress, National Energy Services Reunited, CTO Realty Growth and Kiniksa Pharmaceuticals International 

American Outdoor Brands, Cimpress, National Energy, CTO Realty and Kiniksa stand out for recent price strength backed by earnings growth and estimate revisions.

PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use

Pfizer's Talzenna plus Xtandi combo wins FDA priority review for HRR gene-mutated metastatic castration-sensitive prostate cancer.

Community Health Q2 Loss Wider Than Expected, 2026 View Lowered

CYH posts a wider-than-expected Q2 loss as revenues fall and the company cuts its 2026 revenue, EBITDA and earnings outlook.

$KNSA Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.33 up 37.50% YoY
• Reported revenue of $243.6M up 55.36% YoY
• Kiniksa Pharmaceuticals expects 2026 ARCALYST net product revenue to be between $980 million and $995 million, raised from prior guidance of between $930 million and $945 million for the fiscal year.

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$78.68
Prev Close	$80.20
Open	$79.65
Dividend Yield	0.00%
50-Day Moving Average	$68.68
Beta	0.66
Avg. Volume	781,539.16
PE Ratio	80.00

52-Week High	$82.94
52-Week Low	$33.25
Market Capitalization	$6.26B
EPS (Annual)	$0.7471
Price to Book	9.38
Revenue Per Employee	$1.85M

Feed

News

Sentiment

Earnings

Fundamentals

Info